This inventor holds 6 USPTO granted patents and 5 published patent applications and 2 EPO patents. Top assignees: Baxalta Gmbh, Baxter International Inc., Takeda Pharmaceutical Company Limited. Active years: 1998-2025.
Company Filing History:
3 out of 153 
2 out of 2,531 
2 out of 1,226 
Years Active: 1998-2025
Title: The Innovations of Sharon Pokropinski
Introduction
Sharon Pokropinski is a notable inventor based in Schaumburg, IL (US). She has made significant contributions to the field of medical science, particularly in the treatment of central nervous system disorders. With a total of 6 patents to her name, her work has the potential to impact many lives.
Latest Patents
One of her latest patents focuses on the treatment of central nervous system disorders by intranasal administration of immunoglobulin G. This invention provides methods and compositions for delivering a therapeutically effective amount of pooled human immunoglobulin G (IgG) to the brain. The administration is done directly to the olfactory epithelium of the nasal cavity. In particular, this method aims to treat Alzheimer's disease, showcasing her commitment to addressing critical health issues.
Career Highlights
Throughout her career, Sharon has worked with prominent companies such as Baxalta GmbH and Baxter International Inc. Her experience in these organizations has allowed her to develop and refine her innovative ideas, contributing to her success as an inventor.
Collaborations
Sharon has collaborated with notable individuals in her field, including William Howard Frey, II and Leah Ranae Bresin Hanson. These partnerships have likely enriched her work and expanded the impact of her inventions.
Conclusion
Sharon Pokropinski's contributions to the field of medical science through her innovative patents demonstrate her dedication to improving health outcomes. Her work continues to pave the way for advancements in the treatment of central nervous system disorders.